Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
127.10
-1.67 (-1.29%)
Oct 8, 2025, 3:33 PM EDT
Novartis AG Market Cap
Novartis AG has a market cap or net worth of $257.26 billion as of October 8, 2025. Its market cap has increased by 9.28% in one year.
Market Cap
257.26B
Enterprise Value
283.04B
Revenue
55.19B
Ranking
n/a
PE Ratio
18.84
Stock Price
$127.10
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 127.35B to 257.26B, an increase of 102.02%. That is a compound annual growth rate of 2.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 257.26B | 31.58% |
| Dec 30, 2024 | 195.51B | -5.62% |
| Dec 29, 2023 | 207.17B | 6.54% |
| Dec 30, 2022 | 194.45B | -1.02% |
| Dec 30, 2021 | 196.46B | -8.76% |
| Dec 30, 2020 | 215.32B | 0.17% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |